| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.05 |